These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 572444)

  • 1. [On convulsive reactions following oral vaccination against polio (author's transl)].
    Ehrengut W; Ehrengut-Lange J
    Klin Padiatr; 1979 May; 191(3):261-70. PubMed ID: 572444
    [No Abstract]   [Full Text] [Related]  

  • 2. Convulsions following oral polio immunisation.
    Ehrengut W; Ehrengut J
    Dev Biol Stand; 1979; 43():165-71. PubMed ID: 520668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral vaccination against poliomyelitis and convulsions (author's transl)].
    Joppich G
    Klin Padiatr; 1980 Jul; 192(4):393-4. PubMed ID: 7192776
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination complications after oral poliomyelitis vaccination (author's transl)].
    Bodechtel G; Haas R; Joppich G; Lennartz H; Siegert R
    MMW Munch Med Wochenschr; 1977 Apr; 119(16):521-8. PubMed ID: 17066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Poliomyelitis in the Federal Republic of Germany. A retrospective study of 1973 (author's transl)].
    Neumann-Haefelin D; Newmann-Haefelin C; Baumeister HG; Knocke KW; Petersen EE; Haas R
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2597-602. PubMed ID: 4373221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and electroencephalographic studies of subjects with the West syndrome appearing after poliomyelitis vaccination].
    Marchesi GF; Quattrini A
    Riv Neurol; 1976; 46(5):377-82. PubMed ID: 1025680
    [No Abstract]   [Full Text] [Related]  

  • 7. Time for a worldwide shift from oral polio vaccine to inactivated polio vaccine.
    Shahzad A
    Clin Infect Dis; 2009 Oct; 49(8):1287-8. PubMed ID: 19780666
    [No Abstract]   [Full Text] [Related]  

  • 8. [Virological and clinical study of morbid manifestations connected with anti-poliomyelitis vaccination with the oral Sabin vaccine].
    Marzetti G; Bertolini L; Midulla M
    Minerva Pediatr; 1967 Dec; 19(50):2236-45. PubMed ID: 5304534
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary on the oral poliomyelitis vaccine (Sabin) -- associated cases of acute persisting spinal paralysis.
    Biberi-Moroeanu S; Muntiu A
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):355-68. PubMed ID: 757664
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of paralytic poliomyelitis cases occurring after polio vaccination.
    Basu SN
    J Indian Med Assoc; 1986 Jul; 84(7):203-6. PubMed ID: 3794352
    [No Abstract]   [Full Text] [Related]  

  • 11. Field evaluation of trivalent oral polio vaccine efficacy in Madras city--a case control study.
    Ramasamy DJ
    J Commun Dis; 1994 Sep; 26(3):151-5. PubMed ID: 7868838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the side-effects of poliomyelitis vaccination with the Sabin method].
    Cassata F; Raimondo L
    Pediatria (Napoli); 1970; 78(1):26-43. PubMed ID: 5268249
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of five children with Guillain-Barré syndrome following a nationwide oral polio vaccine campaign in Turkey.
    Anlar O; Tombul T; Arslan S; Akdeniz H; Caksen H; Gundem A; Akbayram S
    Neurol India; 2003 Dec; 51(4):544-5. PubMed ID: 14742945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety aspects of oral poliovirus vaccine campaigns.
    Hovi T
    Dev Biol Stand; 1995; 84():137-44. PubMed ID: 7796946
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methodology of systematic vaccination in infancy (author's transl)].
    Rodríguez Torres A
    An Esp Pediatr; 1974 Sep; 7 Suppl 1(0):84-96. PubMed ID: 4429306
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
    Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
    Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral vaccination against poliomyelitis using trivalent vaccines].
    Damjanowa M; Huber EG; Kraus P; Pötsch F
    Dtsch Med Wochenschr; 1970 Jun; 95(23):1265-8. PubMed ID: 4315949
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary immunization and booster vaccination against polio].
    Müller HE
    Dtsch Med Wochenschr; 1995 May; 120(21):776. PubMed ID: 7781504
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral polio vaccination in 5 vaccination periods. Consumption of vaccine and participation in vaccination].
    von Magnus H; Petersen I; Bentzon MW
    Ugeskr Laeger; 1973 Jan; 135(2):93-6. PubMed ID: 4702324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.